Vegan Pharmaceutical Formulation Development

Zero Animal Biotech is a pre-commercial R&D biotech company developing vegan formulations for generic medications—free from lactose and animal-derived excipients like magnesium stearate.

The Problem

65%

Lactose intolerant globally

Most hormonal medications contain lactose as an excipient, causing digestive issues for billions worldwide

30%

Avoid animal products for religious reasons

Muslims, Jews, and Hindus concerned about animal-derived ingredients like magnesium stearate

68%

Interested in plant-based options

Growing consumer interest in adding plant-based products, particularly among younger demographics

Our Mission

Develop vegan formulations for generic medications that eliminate lactose and all animal-derived ingredients, starting with Dienogest for endometriosis treatment.

First Development: Dienogest

A hormonal medication for endometriosis affecting 10% of people with a uterus globally—currently only available with lactose and animal-derived excipients.

Partnership with India

We've partnered with India's largest CDMO to test and validate our vegan formulations for future licensing to pharmaceutical distributors.

For Investors

Zero Animal Biotech addresses multiple underserved pharmaceutical markets with a single innovative solution

Market Convergence

Our vegan formulation platform captures three mega-trends simultaneously: lactose-free pharmaceuticals, halal/kosher medical alternatives, and the global vegan movement.

$2B+

Global Dienogest Market

200M+

Target Patients in Latin America

0

Vegan Competitors

Development

Pre-commercial R&D phase developing vegan formulations with India's largest CDMO

Licensing Model

License formulations to regulated pharmaceutical distributors—we never engage in direct sales or distribution

Scalable Platform

Expand from Dienogest to other generic medications using our vegan formulation expertise

Why Zero Animal Biotech

First-Mover Advantage

No existing vegan formulations for hormonal generics—massive untapped market opportunity

Proven Partnership

Collaboration with India's largest CDMO ensures manufacturing readiness and scalability

Multi-Market Appeal

Single solution serves lactose-intolerant, religious, and vegan consumer segments

Asset-Light Model

Licensing strategy minimizes capital requirements and regulatory complexity

Contact Us

For investor inquiries and partnership opportunities